Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Conditions:   Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsors:   National Cancer Institute (NCI);   North Central Cancer Treatment Group;   NSABP Foundation Inc;   Cancer and Leukemia Group B;   Southwest Oncology Group;   NCIC Clinical Trials Group;   American College of SurgeonsActive, not recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials